Search results
Results From The WOW.Com Content Network
Achieving this goal would require the development of therapeutic treatments to cure chronic hepatitis B, as well as preventing its transmission and using vaccines to prevent new infections. [15] [16] [17] An estimated 296 million people, or 3.8% of the global population, had chronic hepatitis B infections as of 2019.
For the medical community, the Hepatitis B Foundation organizes the International HBV Scientific Meeting annually for scientists discuss to new discoveries in hepatitis B research. [12] The organization is also actively involved in policy-making, helping ensure hepatitis B is a health priority at the local and federal level. [13] [14] [15]
Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company Novartis under the trade names Sebivo (European Union) and Tyzeka (United States). Clinical trials have shown it to be significantly more effective than lamivudine or adefovir, and less likely to cause resistance.
Lamivudine has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV/AIDS. It improves the seroconversion of e-antigen positive hepatitis B and also improves histology staging of the liver. Long-term use of lamivudine leads to emergence of a resistant hepatitis B virus (YMDD) mutant. [11]
Dr Sema Mandal, deputy director for blood-borne viruses at the UKHSA, said many people were unaware they have hep B – or another type of hepatitis, hep C – “because the viruses can be ...
HBsAg (hepatitis B surface antigen) was the first hepatitis B virus protein to be discovered. [15] It consists of small (S), medium (M) and large (L) protein. [16] HBcAg (hepatitis B core antigen) is the main structural protein of HBV icosahedral nucleocapsid and it has function in replication of the virus. [17]
Hepatitis B immunoglobulin (HBIG) is a human immunoglobulin that is used to prevent the development of hepatitis B [2] and is used for the treatment of acute exposure to HBsAg. [ 3 ] [ 4 ] [ 5 ] Medical uses
US stocks ended Friday in the red, closing out a lackluster week despite a year of historic highs.. The Dow was lower by 333 points, or 0.78%, after the closing bell.